Cargando...
Structural modification of aspirin to design a new potential cyclooxygenase (COX-2) inhibitors
Aspirin (Asp) is one of the most important and ancient member of nonsteroidal anti-inflammatory drugs (NSAID), commonly used in medication of fever, pain and inflammation. It can inhibit the synthesis of prostaglandin by blocking the cyclooxygenase (COX). Attempts have been taken to analyze aspirin...
Gardado en:
| Publicado en: | In Silico Pharmacol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Springer Berlin Heidelberg
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7056757/ https://ncbi.nlm.nih.gov/pubmed/32181121 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40203-020-0053-0 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|